
CC
Chemours Company (The)
$21.94
+$0.57(+2.67%)
54
Overall
60
Value
63
Tech
39
Quality
Market Cap
$1.93B
Volume
1.47M
52W Range
$9.13 - $50.00
Target Price
$26.22
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $5.4B | $6.2B | $6.6B | $5.5B | $5.0B | $6.3B | $6.8B | $6.1B | $5.8B | $5.8B | ||
| Total Revenue | $5.4B | $6.2B | $6.6B | $5.5B | $5.0B | $6.3B | $6.8B | $6.1B | $5.8B | $5.8B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-4.3B | $-4.4B | $-4.7B | $4.5B | $3.9B | $5.0B | $5.2B | $4.8B | $4.6B | $4.9B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $1.1B | $1.7B | $2.0B | $1.1B | $1.1B | $1.4B | $1.6B | $1.3B | $1.1B | $902.0M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-1.2B | $-764.0M | $-788.0M | $715.0M | $700.0M | $705.0M | $830.0M | $1.6B | $823.0M | $966.0M | ||
| Research & Development | $80.0M | $81.0M | $82.0M | $80.0M | $93.0M | $107.0M | $118.0M | $108.0M | $109.0M | $108.0M | ||
| Research Expense | $80.0M | $81.0M | $82.0M | $80.0M | $93.0M | $107.0M | $118.0M | $108.0M | $109.0M | $108.0M | ||
| Selling, General & Administrative | $936.0M | $917.0M | $808.0M | $548.0M | $527.0M | $592.0M | $710.0M | $1.3B | $598.0M | $799.0M | ||
| Selling & Marketing Expenses | $934.0M | $765.0M | $808.0M | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $2.0M | $152.0M | $-81.0M | $548.0M | $527.0M | $592.0M | $710.0M | $1.3B | $598.0M | $799.0M | ||
| Promotion & Advertising | -- | -- | $151.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-20.0M | $-29.0M | $-24.0M | $381.0M | $14.0M | $6.0M | $27.0M | -- | -- | -- | ||
| Depreciation & Amortization | $-10.0M | $-273.0M | $-284.0M | $311.0M | $320.0M | $317.0M | $291.0M | $307.0M | $301.0M | -- | ||
| Depreciation & Amortization | $-10.0M | $-273.0M | $-284.0M | $311.0M | $320.0M | $317.0M | $291.0M | -- | -- | -- | ||
| Amortization | $-10.0M | -- | -- | $158.0M | $161.0M | $114.0M | $110.0M | $111.0M | $55.0M | -- | ||
| Other Operating Expenses | $157.0M | $57.0M | $49.0M | $-87.0M | $-80.0M | $-6.0M | $-6.0M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-48.0M | $690.0M | $1.0B | $522.0M | $527.0M | $688.0M | $788.0M | $-92.0M | $435.0M | $-5.0M | ||
| EBITDA | $506.0M | $1.4B | $1.7B | $404.0M | $709.0M | $1.2B | $1.2B | $206.0M | $673.0M | $343.0M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $213.0M | $214.0M | $195.0M | $208.0M | $210.0M | $185.0M | $163.0M | $208.0M | $263.0M | $269.0M | ||
| Intinc | $-47.0M | -- | $1.0B | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-198.0M | $-214.0M | $700.0M | $-208.0M | $-210.0M | $-185.0M | $-163.0M | $-208.0M | $-263.0M | $-269.0M | ||
| Gain on Sale of Securities | $-1.0M | $122.0M | $1.0B | -- | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $-228.0M | $-2.2B | $-1.3B | $264.0M | $-22.0M | $-185.0M | $118.0M | $-135.0M | $-50.0M | $-56.0M | ||
| Other Special Charges | $247.0M | $26.0M | $120.0M | $-293.0M | $-1.0M | $142.0M | $77.0M | $90.0M | $7.0M | $21.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-4.0M | $-24.0M | $-14.0M | $44.0M | $20.0M | $-2.0M | $9.0M | -- | -- | -- | ||
| Special Income Charges | $482.0M | $-1.0M | $-151.0M | $-219.0M | $-69.0M | $2.0M | $-9.0M | $-109.0M | $-56.0M | -- | ||
| Impairment of Capital Assets | $-119.0M | $-1.0M | $-4.0M | -- | -- | -- | -- | $97.0M | $56.0M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $202.0M | $1.1B | $1.4B | $84.0M | $389.0M | $861.0M | $904.0M | $-110.0M | $369.0M | $-8.0M | ||
| Pre-Tax Income | $-11.0M | $912.0M | $1.2B | $-124.0M | $179.0M | $676.0M | $741.0M | $-318.0M | $106.0M | $-277.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-18.0M | $165.0M | $159.0M | $-72.0M | $-40.0M | $68.0M | $163.0M | $-81.0M | $37.0M | $109.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-47.0M | $2.5B | $2.7B | $-52.0M | $219.0M | $608.0M | $578.0M | $-238.0M | $69.0M | $-386.0M | ||
| Net Income (Continuing Operations) | $-47.0M | $2.5B | $2.7B | $-52.0M | $219.0M | $608.0M | $578.0M | $-237.0M | $69.0M | $-386.0M | ||
| Net Income (Discontinued Operations) | $-47.0M | $2.5B | $2.7B | $-52.0M | $219.0M | $608.0M | $578.0M | $-238.0M | $69.0M | $-386.0M | ||
| Net Income (Common Stockholders) | $-47.0M | $2.5B | $2.7B | $122.0M | $219.0M | $608.0M | $578.0M | $-238.0M | $69.0M | $-386.0M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-274.2M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-5.5B | $-5.2B | $-5.5B | $5.2B | $4.6B | $5.7B | $6.0B | $6.3B | $5.5B | $5.9B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $181.6M | $184.8M | $177.0M | $164.8M | $164.7M | $164.9M | $155.4M | $16.9M | $-13.8M | $150.2M | ||
| Average Shares Outstanding (Diluted) | $183.4M | $191.0M | $182.6M | $164.8M | $166.3M | $168.7M | $158.3M | $16.9M | $-200.0M | $150.2M | ||
| Shares Outstanding | $183.2M | $182.5M | $167.0M | $164.0M | $165.2M | $160.0M | $148.3M | $148.8M | $149.4M | $150.1M | ||
| Basic EPS | $0.04 | $4.04 | $5.62 | $-0.32 | $1.33 | $3.69 | $3.72 | $-1.6 | $0.58 | $-2.57 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-0.32 | $1.33 | $3.69 | $3.72 | $-1.6 | $0.58 | $-2.57 | ||
| Diluted EPS | $0.04 | $3.91 | $5.45 | $-0.32 | $1.32 | $3.6 | $3.65 | $-1.6 | $0.57 | $-2.57 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-0.32 | $1.32 | $3.6 | $3.65 | $-1.6 | $0.57 | $-2.57 | ||
| Dividend Per Share | $0.12 | $0.12 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $0.51 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D | $15.0M | $79.0M | $8.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | -- | $1.0B | $38.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Allowances For Construction | -- | -- | $-17.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Depletion | $-13.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $28.0M | $33.0M | $43.0M | $29.0M | $23.0M | $43.0M | $55.0M | $45.0M | $43.0M | $35.0M | ||
| Earnings From Equity Interest Net Of Tax | $28.0M | $33.0M | $43.0M | $29.0M | $23.0M | $43.0M | $55.0M | $45.0M | $43.0M | $35.0M | ||
| Fees | -- | -- | $17.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $254.0M | $995.0M | $8.0M | $10.0M | $8.0M | -- | -- | -- | -- | -- | ||
| Insurance And Claims | -- | -- | $1.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-3.0M | $1.0M | $8.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | $-1.0M | $-1.0M | $695.0M | $815.0M | $-1.0M | $-1.0M | $-1.0M | -- | -- | ||
| Net Operating Interest Income Expense | $-213.0M | $-214.0M | $-195.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | $-359.0M | $-9.0M | $-82.0M | $175.0M | $49.0M | $230.0M | -- | -- | -- | -- | ||
| Other Gand A | $2.0M | $152.0M | $-81.0M | $548.0M | $527.0M | $592.0M | $710.0M | $1.3B | $598.0M | $799.0M | ||
| Other Impairment Of Capital Assets | $-13.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Write Down | -- | $152.0M | -- | -- | -- | -- | $1.0M | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | $1.0M | -- | -- | -- | -- | ||
| Realized Capital Gain | -- | $1.0B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $2.0M | $152.0M | $-1.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $934.0M | $626.0M | $657.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | $-13.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Write Off | -- | $152.0M | $151.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | $1.0M | $-10.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-4.0M | $-24.0M | $-14.0M | $44.0M | $20.0M | $-2.0M | $9.0M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CC | $21.94 | +2.7% | 1.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |